Skip to content

Effect of nalbuphine preventive analgesia on visceralgia of patients undergoing laparoscopic cholecystectomy: a multicentre randomized controlled study

Effect of nalbuphine preventive analgesia on visceralgia of patients undergoing laparoscopic cholecystectomy: a multicentre randomized controlled study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014379
Enrollment
Unknown
Registered
2018-01-09
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Group N:In the experimental group, intravenous infusion of nalbuphine 0.2mg/kg for 15 minutes before skin incision
Group P:give NS 15 minutes before skin incision

Sponsors

Department of anesthesiology, The Second Hospital Of AnHui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing laparoscopic cholecystectomy, ASA I-II; 2. aged 18-65 years; 3. BMI (Body Mass Index) 18.5~30 kg/m2; 4. With normal communication and certain learning ability; 5. Having signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Serious respiratory or circulatory diseases: such as severe atherosclerosis of coronary artery, cardiac failure, myocardial infarction, respiratory failure; 2. Neurological diseases: such as severe cerebral hemorrhage or cerebral infarction , hemiplegia or aphasia; 3. Mental illness: such as schizophrenia or depression; 4. Long-term abuse of drugs: including chemotherapy drugs and analgesics; 5. Obvious liver or kidney dysfunction; 6. Pregnant and lactating women; 7. allergy to opioid.

Design outcomes

Primary

MeasureTime frame
VAS score;

Secondary

MeasureTime frame
Extubation time;restlessness;time in PACU;Vital signs at each time point after surgery;Ramsay score;The quality of sleep;supplementary analgesic drugs;Postoperative adverse reaction;satisfaction;

Countries

China

Contacts

Public ContactYe Zhang

The Second Hospital Of AnHui Medical University

zhangye_hassan@sina.com+86 13966768081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026